Bloomberg on MSN3mon
Sandoz Plans First GLP1 Generic Drug Launch in Canada in 2026(Bloomberg) -- Sandoz Group AG plans to launch a semaglutide generic drug in Canada when the patent for the main ingredient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback